An official website of the United States governmentResources for Technical Assistance
- NIH SEED FAQs
- Success Stories (NIH SEED)
- 2021 HHS Small Business Program Conference Materials
- Creating your Roadmap - The Importance of Developing Effective Milestones and Project Management (NHLBI Webinar)
- i-Corps™ at NIH—A competitive 8-week, hands-on program that provides funding, mentoring, and networking opportunities to help commercialize your promising biomedical technology.
- Applicant Assistance Program—A competitive, no-cost 10-week customized coaching program to help small businesses apply for Phase I SBIR/STTR funding.
- Technical and Business Assistance Program—Helps small businesses identify and address product development needs.
- NIH SBIR Resources—Discover the comprehensive suite of resources to help small businesses submit applications and commercialize their technologies.
- Blueprint MedTech Program—An NIH incubator to support innovators by accelerating the development of cutting-edge medical devices to diagnose or treat disorders of the nervous system.
- Draft Specific Aims—After you have decided the area of research to pursue, start thinking about your planned projects by first drafting objectives, known in NIH lingo as Specific Aims.
- Sample Applications
- NIAID Samples (R41, R42, R43, and R44)
- NIA Samples
- Blog Posts
- Planning To Apply for a Small Business Innovation Research Award in January 2021? (September 14, 2020)
- Tips for Small Business Grant Applicants Considering NCCIH (August 14, 2019)
- Changes to SBIR-STTR Programs Are Here (June 28, 2019)
- NCCIH’s SBIR/STTR Programs: Funding Small Business Research and Development (February 20, 2018)
For applications involving clinical studies that fall within the NIH definition of a clinical trial, NCCIH will not support clinical trials aiming to test efficacy/effectiveness (meaning the study is powered on a primary outcome that is a clinical assessment used in clinical diagnosis of disease or monitoring of disease severity) of an intervention as a part of an SBIR/STTR Phase I application. Applicants seeking to conduct efficacy or effectiveness clinical trials should pursue funding via other FOAs such as the Omnibus SBIR/STTR Phase II, Direct to Phase II, and Fast-Track. See NOT-AT-19-012 for “NCCIH Policy for SBIR and STTR Phase I Applications Proposing Clinical Trials to the Omnibus Solicitations.”
For applications involving clinical studies that fall within the NIH definition of a clinical trial, NCCIH will not support clinical trials aiming to test efficacy/effectiveness (meaning the study is powered on a primary outcome that is a clinical assessment used in clinical diagnosis of disease or monitoring of disease severity) of an intervention as a part of an SBIR/STTR Phase I application. Applicants seeking to conduct efficacy or effectiveness clinical trials should pursue funding via other FOAs such as the Omnibus SBIR/STTR Phase II, Direct to Phase II, and Fast-Track.
Not sure if your research is a clinical trial? The NIH definition of a clinical trial is, “A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.” For additional information on NCCIH’s clinical trial policy, visit our Clinical Trials section.